Prot#C928-011: A Randomized, Double-blind, Placebo-controlled, Phase 2b study to Evaluate Safety and Efficacy of DUR-928 in Subjects with Alcoholic Hepatitis

Project: Research project

Project Details

StatusActive
Effective start/end date2/5/21 → 2/5/24

Funding

  • CTI Clinical Trial and Consulting Services (Prot#C928-011)
  • DURECT Corporation (Prot#C928-011)